Research Topics
Species | S StadlmannSummaryAffiliation: University of Innsbruck Country: Austria Publications
| Collaborators
|
Detail Information
Publications
Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusionsSylvia Stadlmann
Department of Pathological Anatomy, Innsbruck Medical University, A 6020 Innsbruck, Austria
Gynecol Oncol 97:784-9. 2005..We compared the VEGF secretion by human peritoneal mesothelial cells (HPMC) and ovarian carcinoma (OVCA) cells and its regulation by pro-inflammatory cytokines...- Heparanase-1 gene expression in normal, hyperplastic and neoplastic prostatic tissueS Stadlmann
Institute of Pathology, University of Innsbruck, Muellerstrasse 44, 6020 Innsbruck, Austria
Eur J Cancer 39:2229-33. 2003..Hpa-1 mRNA expression in the tumours significantly correlated with tumour differentiation and tumour stage (P<0.05). Our data indicate that Hpa-1 gene expression may be lost during dedifferentiation of prostatic gland cells... - Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancerS Stadlmann
Institute of Pathology, University of Innsbruck, Muellerstrasse 44, 6020 Innsbruck, Austria
Eur J Cancer 39:2499-505. 2003..01). The data indicate that MMP-8 overexpression in OVCAs is regulated by IL-1beta and that pro-inflammatory cytokines may promote the invasive potential of ovarian cancer... - Mitochondrial defects by intracellular calcium overload versus endothelial cold ischemia/reperfusion injuryE Gnaiger
Department of Transplant Surgery, University Hospital Innsbruck, Austria
Transpl Int 13:S555-7. 2000..In contrast, Ca2+ overload caused uncoupling of mitochondrial respiration. High intracellular Ca2+ overload, therefore, does not reproduce cold ischemia/reperfusion injury in endothelial cells... - Primary iron overload with inappropriate hepcidin expression in V162del ferroportin diseaseHeinz Zoller
Clinical Division of Gastroenterology and Hepatology, Innsbruck Medical University, Innsbruck, Austria
Hepatology 42:466-72. 2005..Finally, macrophage iron storage in ferroportin disease is associated with elevated serum pro-hepcidin levels... - Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia)Gunda Millonig
Clinical Division of Gastroenterology and Hepatology, Medical University of Innsbruck, Austria
Eur J Gastroenterol Hepatol 17:445-7. 2005..To our knowledge, this is the first report of hepatotoxicity caused by this herbal remedy, which has been highly praised in the tabloid press... - A cost comparison of telepathology and a visiting pathologist servicePatrizia L Moser
Department of Pathology, University of Innsbruck, Austria
J Telemed Telecare 9:200-3. 2003..The present case-load (eight cases per month) at the study hospital was below this threshold... - The accuracy of telediagnosis of frozen sections is inferior to that of conventional diagnosis of frozen sections and paraffin-embedded sectionsPatrizia L Moser
Department of Pathology, University of Innsbruck, Austria
J Telemed Telecare 9:130-4. 2003.... - Ciprofloxacin-induced acute liver injury: case report and review of literatureAnnette Zimpfer
Institute of Pathology, University of Basel, Schoenbeinstrasse 40, 4003 Basel, Switzerland
Virchows Arch 444:87-9. 2004..Symptoms resolved after corticoidsteroid therapy. In the present paper, we report the clinico-pathological characteristics of a case of ciprofloxacin-associated acute hepatic failure and discuss the current literature... - ERCC1-immunoexpression does not predict platinum-resistance in ovarian cancerSylvia Stadlmann
Gynecol Oncol 108:252-3. 2008 - Glypican-3 expression in primary and recurrent ovarian carcinomasSylvia Stadlmann
Institute of Pathology, University Hospital Basel, Basel, Switzerland
Int J Gynecol Pathol 26:341-4. 2007..In conclusion, our data show that GPC3 is observed in a significant fraction of primary and corresponding recurrent ovarian carcinomas. Glypican-3 may therefore represent a potential target for (second-line) therapy in ovarian cancer... - Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patientsDaniel Reimer
Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria
Clin Cancer Res 13:144-51. 2007..We therefore investigated the relevance of the whole set of E2F family members in predicting clinical outcome and their significance in predicting platinum resistance... - Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginaseMichael Bodmer
Division of Clinical Pharmacology and Toxicology, University Hospital, Basel, Switzerland
Digestion 74:28-32. 2006..Both impaired liver mitochondrial function and alterations in very-low-density lipoprotein metabolism and secretion are discussed as two possible mechanisms explaining the findings observed in this patient... - Clinico-histopathological characteristics of clopidogrel-induced hepatic injury: case report and review of literatureIsolde Höllmüller
Department of Gastroenterology and Hepatology, Innsbruck Medical University, Austria
Eur J Gastroenterol Hepatol 18:931-4. 2006..In the present paper, we describe the clinico-histopathological characteristics of a case of clopidogrel-induced acute hepatitis and discuss the current literature... - Expression of peroxisome proliferator activated receptor gamma and cyclo-oxygenase 2 in primary and recurrent ovarian carcinomaSylvia Stadlmann
Institute of Pathology, University Hospital Basel, Basel, Switzerland
J Clin Pathol 60:307-10. 2007..Peroxisome proliferator-activated receptor gamma (PPARgamma) has emerged as a potential therapeutic target in several types of cancer. In ovarian carcinomas, limited and conflicting data on PPARgamma protein expression have been reported... - Response of human peritoneal mesothelial cells to inflammatory injury is regulated by interleukin-1beta and tumor necrosis factor-alphaSylvia Stadlmann
Institute of Pathology, University of Basel, Basel, Switzerland
Wound Repair Regen 14:187-94. 2006..Our data indicate that the response of HPMC to inflammatory injury is regulated by interleukin-1beta and TNF-alpha reflecting their putative role in peritoneal wound healing and adhesion formation... - Epithelial growth factor receptor status in primary and recurrent ovarian cancerSylvia Stadlmann
Institute for Pathology, University Hospital of Basel, Basel, Switzerland
Mod Pathol 19:607-10. 2006..003). In recurrent carcinoma, moderate and strong EGFR expression was associated with amplification (P = 0.034). These molecular events potentially have impact on the responsiveness to EGFR targeting agents in ovarian cancer... - Preserved coupling of oxidative phosphorylation but decreased mitochondrial respiratory capacity in IL-1beta-treated human peritoneal mesothelial cellsSylvia Stadlmann
Department of Pathological Anatomy, University Hospital Innsbruck, Austria
Cell Biochem Biophys 44:179-86. 2006.... - Disruption of the integrity of human peritoneal mesothelium by interleukin-1beta and tumor necrosis factor-alphaSylvia Stadlmann
Institute of Pathology, University of Innsbruck, 6020, Innsbruck, Austria
Virchows Arch 443:678-85. 2003.... - 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patientsAlexander Perathoner
Tyrolean Cancer Research Institute, Innsbruck, Austria
Clin Cancer Res 11:3274-9. 2005..In this study, we examined the expression of 14-3-3sigma and evaluated its clinical significance in colorectal carcinoma... - Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samplesDaniel Baumhoer
Institute of Pathology, University Hospital Basel, Basel, Switzerland
Am J Clin Pathol 129:899-906. 2008..Furthermore, several other tumors revealed consistent expression of GPC3, including squamous cell carcinoma of the lung (27/50 [54%]), testicular nonseminomatous germ cell tumors (32/62 [52%]), and liposarcoma (15/29 [52%])...